CHEMOCENTRYX SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ChemoCentryx, Inc. – CCXI

NEW ORLEANS–(BUSINESS WIRE) – Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors they have up July 6, 2021 Filing lead plaintiffs in a class action lawsuit against ChemoCentryx, Inc. (NasdaqGS: CCXI) if they purchased the company’s shares between November 26, 2019 and May 3, 2021 inclusive (the “Collection Period”). This lawsuit is pending in the United States District Court for the Northern District of California.

What you can do

If you have purchased ChemoCentryx shares and would like to discuss your statutory rights and the possible impact this case may have on you and your right to reimbursement of your economic loss, you can contact KSF’s managing partner, Lewis Kahn, free of charge, at no obligation or cost 1-877-515-1850 or email ([email protected]) or visit https://www.ksfcounsel.com/cases/nasdaqgs-ccxi/ to learn more. If you want to appear as the lead plaintiff in this class action lawsuit, you must file a motion with the court July 6, 2021.

About the lawsuit

ChemoCentryx and some of its executives are accused of failing to disclose material information during the classroom, in violation of federal securities laws.

On May 4, 2021, the U.S. Food and Drug Administration released briefing papers on the company’s drug candidate Avacopan.[c]Study design complexities … raise questions about the interpretability of the data to define a clinically meaningful benefit of Avacopan “and that the review” identified several problem areas, which increases the uncertainty about the interpretability of the data and the clinical power of these results. ”

In that news, ChemoCentryx shares fell approximately 45%, trading at $ 26.63 per share on May 4, 2021.

The case is Homyk v ChemoCentryx, Inc. et al., No. 3: 21-cv-03343.

About Kahn Swick & Foti, LLC

KSF, partnered with former Louisiana Attorney General Charles C. Foti Jr., is one of the leading securities litigation law firms in the country. KSF assists a wide variety of clients – including public institutional investors, hedge funds, money managers and private investors – in their search for investment losses due to corporate fraud and misconduct by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you can visit www.ksfcounsel.com.